Antiapoptotic effect of benzyloxycarbonyl-aspartyl-(β-tertier-butyl ester)-bromomethylketone (z-d(otbu)-bmk), an intermediate of interleukin-lβ converting enzyme inhibitors
- 30 April 1997
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 19 (4) , 215-225
- https://doi.org/10.1016/s0192-0561(97)00026-x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Apoptosis: Molecular Regulation of Cell DeathEuropean Journal of Biochemistry, 1996
- An interleukin‐1β‐converting enzyme‐like protease is a common mediator of apoptosis in thymocytesFEBS Letters, 1995
- Peptide inhibitors of the ice protease family arrest programmed cell death of motoneurons in vivo and in vitroNeuron, 1995
- Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosisNature, 1995
- Involvement of an ICE-like protease in Fas-mediated apoptosisNature, 1995
- Aspartate-Based Inhibitor of Interleukin-1β-Converting Enzyme Prevents Antitumor Agent-Induced Apoptosis in Human Myeloid Leukemia U937 CellsBiochemical and Biophysical Research Communications, 1995
- Altered Cytokine Export and Apoptosis in Mice Deficient in Interleukin-1β Converting EnzymeScience, 1995
- Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shockCell, 1995
- P1 Aspartate-Based Peptide .alpha.-((2,6-Dichlorobenzoyl)oxy)methyl Ketones as Potent Time-Dependent Inhibitors of Interleukin-1.beta.-Converting EnzymeJournal of Medicinal Chemistry, 1994
- Synthesis of a potent, reversible inhibitor of interleukin-1β converting enzymeBioorganic & Medicinal Chemistry Letters, 1992